Methemoglobinemia induced by lidocaine-prilocaine cream.
Oded Shamriz, Inbal Cohen-Glickman, Shimon Reif, Eyal Shteyer
Index: Isr. Med. Assoc. J. 16(4) , 250-4, (2014)
Full Text: HTML
Abstract
With growing awareness of the importance of pain control in all procedures, the use of lidocaine-prilocaine cream (EMLA) for all ages is increasing. Lidocaine-prilocaine cream has been implicated as a cause of methemoglobinemia. Diagnostic clues may be oxygen-resistant cyanosis and an oxygen "saturation gap" between arterial blood saturation and pulse oximetry. Treatment with intravenous methylene blue is often effective. Since EMLA is often mistakenly considered risk-free it is routinely applied by medical staff in the emergency room. Subsequent to the case of EMLA-induced methemoglobinemia in an 8 year old girl we wish to alert the medical community to this phenomenon, and in this work review the relevant literature.
Related Compounds
Related Articles:
2014-10-01
[J. Neurophysiol. 112(7) , 1628-43, (2014)]
2014-10-01
[J. Biomol. Screen. 19(9) , 1266-74, (2014)]
2015-05-12
[Biochemistry 54 , 2841-50, (2015)]
2014-12-01
[J. Biochem. Mol. Toxicol. 28(12) , 568-77, (2014)]
2015-01-01
[PLoS ONE 10 , e0134768, (2015)]